Boardroom Alpha Digest: Weds, Mar 1

by | Mar 1, 2023

Executive News

  • Richard De Schutter and Dr. Argeris Karabelas will step down from the Board of Bausch Health Companies (BHC)
  • Robert William Bennett officially took over as CEO and a Director at Innovative Food Holdings Inc. (IVFH)
  • Sean Menke, CEO of Sabre Corporation (SABR), will transition the CEO role to Kurt J. Ekert who is the current President. Menke will remain Executive Chair of the Board

Activism

  • Amidst an potential proxy battle with Elliott Investments, Salesforce (CRM) shares surged after hours on a strong earnings report

IPOs Upcoming

  • Opti-Harvest (OPHV) is looking at price ~$6.5M at a $3.5 – $4.0 range
  • NAVA HEALTH MD, LLC (NAVA) is looking to price $8.1M at $5 per share
  • Ultimax Digital, Inc. (NFTX) is looking to price ~$8.5M at a $4.0 – $5.0 range

SPACs

  • Sagalim Acquisition Corp. (SAGA) and Saudi Arabia Entertainment Corp.‘s merger agreement was called off by AEC due to the SPAC’s inability to raise enough committed financing to meet 50% of the min. cash requirement. The SPAC’s CEO is fighting a $1mm termination fee and attempting to sell its interest in the SPAC.
  • Capitalworks Emerging Markets Acquisition (CMCA) and Lexasure Financial agreed to combine in a business combination agreement

SPAC Calendar

Recent Analysis

Daily SPAC Update – March 27, 2024

KYCH + ZOOZ Power Ltd Deal Vote. DSAQ, VHAQ Extension Votes. CNDB deSPACs to GCTS. APZI + Omnigenics AI Announced. LGVC Delays to April 1. FEXD Vote Set. NVAC Extends.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.